There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Roche Holding AG (RHHVF) and Sanofi (SNYNF) with bullish sentiments.
Roche Holding AG (RHHVF)
In a report released today, Michael Leuchten from UBS maintained a Buy rating on Roche Holding AG, with a price target of CHF370.00. The company’s shares closed last Wednesday at $320.55.
Leuchten has an average return of 3.9% when recommending Roche Holding AG.
According to TipRanks.com, Leuchten is ranked #4813 out of 7012 analysts.
Currently, the analyst consensus on Roche Holding AG is a Moderate Buy with an average price target of $409.56, a 26.8% upside from current levels. In a report issued on October 15, Goldman Sachs also maintained a Buy rating on the stock with a CHF442.00 price target.
See today’s analyst top recommended stocks >>
Sanofi (SNYNF)
UBS analyst Laura Sutcliffe maintained a Buy rating on Sanofi today and set a price target of EUR100.00. The company’s shares closed last Wednesday at $97.50.
Sutcliffe has an average return of 0.9% when recommending Sanofi.
According to TipRanks.com, Sutcliffe is ranked #2747 out of 7012 analysts.
Currently, the analyst consensus on Sanofi is a Strong Buy with an average price target of $123.59, implying a 33.4% upside from current levels. In a report issued on October 15, J.P. Morgan also maintained a Buy rating on the stock with a EUR106.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SNYNF:
